Andrew Alliance will be joining Cambridge Healthtech’s 4th Annual Immuno-Oncology Summit in Boston from August 29th- Sept 1st. This summit has been designed to support a coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development and into the market. This weeklong, nine-meeting set will include topics ranging from early discovery through clinical development as well as emerging areas such as oncolytic virotherapy. Overall, this event will provide a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies. Come visit Andrew Alliance at booth 23 to see how our technology is helping oncolgy research worldwide.